About iRhythm Technologies
iRhythm Technologies is transforming the way cardiac arrhythmias are clinically diagnosed through its ZioXT and ZioAT patch-based cardiac monitoring system. The Zio patch provides up to 14 days of continuous ECG recording, combined with AI-driven analysis on the ZioSuite platform to detect atrial fibrillation, supraventricular tachycardia and other arrhythmias in ambulatory patients.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to iRhythm Technologies. Response typically within 48 hours.
Company Info
TypePublic
StockIRTC (NASDAQ)
Founded2006
Employees1,200
Revenue$480M
HQSan Francisco, USA